AFC-HD AMS Life Science Co., Ltd. entered into a basic agreement to acquire 80.2% stake in Nasubi, K.K. from Keisuke Fujita, Hisanori Fujita and others.
April 13, 2021
Share
AFC-HD AMS Life Science Co., Ltd. (JASDAQ:2927) entered into a basic agreement to acquire 80.2% stake in Nasubi, K.K. from Keisuke Fujita, Hisanori Fujita and others on April 14, 2021. In a related transaction, AFC-HD AMS Life Science Co., Ltd. (JASDAQ:2927) entered into a basic agreement to acquire to acquire remaining 20% stake in Nasubi, K.K. from Keisuke Fujita, Hisanori Fujita and others in a share exchange. Post the transaction, Nasubi will become consolidated subsidiary of AFC-HD AMS Life Science. As part of the transaction, AFC-HD AMS Life Science will purchase 24,063 shares of Nasubi, representing 80% stake and regarding the acquisition price, we plan to acquire it at the same ratio in share exchange. Nasubi has net worth of ¥1.1 billion, total assets of ¥1.7 billion, revenue of ¥1.4 billion, operating income of -¥97 million and net income of -¥89 million for the year ended on July 2020. The transaction is expected to close on May 10, 2021. The transaction is expected to close on June 1, 2021.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
AFC-HD AMS Life Science Co., Ltd. entered into a basic agreement to acquire 80.2% stake in Nasubi, K.K. from Keisuke Fujita, Hisanori Fujita and others.
AFC-HD AMS LIFE SCIENCE CO., LTD. 
